LDS/Medical Tests/Pyrimidine 5' Nucleotidase, Blood

Pyrimidine 5' Nucleotidase, Blood

Pyrimidine 5’-nucleotidase (P5'N) is an intracellular enzyme that hydrolyzes pyrimidine nucleotides, removing the 5’ phosphate group to generate nucleosides such as uridine and cytidine for use in nucleic acid metabolism. The enzyme is widely distributed but is particularly abundant in the liver, kidneys, and erythrocytes, where nucleotide metabolism is highly active.

Inherited deficiency of P5'N (caused by inactivating mutations in the NT5C3A gene) is the third most common red blood cell enzyme defect after glucose-6-phosphate dehydrogenase (G6PD) and pyruvate kinase deficiencies. It leads to accumulation of pyrimidine nucleotides in erythrocytes, resulting in hereditary non-spherocytic hemolytic anemia. Clinical features include mild to moderate hemolysis, reticulocytosis, and basophilic stippling on peripheral smear. In some cases, coexistent hemoglobin E can exacerbate anemia severity.

Acquired decreases in enzyme activity are also seen in lead poisoning, leukemia, and certain immunodeficiencies. Measurement of P5'N activity provides valuable information in the evaluation of unexplained hemolytic anemias and differential diagnosis of red blood cell enzyme deficiencies.

  • As an aid in differential diagnosis of congenital and acquired hemolytic anemias
  • Useful in the diagnosis of hematologic malignancies and marrow disorders with abnormal nucleotide metabolism
  • Evaluation of marked basophilic stippling in anemia cases and lead poisoning

Decreased activity:

  • Hereditary non-spherocytic hemolytic anemia due to P5'N deficiency
  • Acquired hemolytic anemia
  • Autoimmune hemolytic anemia
  • Lead poisoning
  • Leukemia and other hematologic malignancies
  • Selected immunodeficiencies

Normal (not well established)

Chemiluminescence immunoassay (CLIA). Alternative methods include spectrophotometric enzyme activity assays.

Whole blood, yellow top (ACD).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: unacceptable
CBC with differential, reticulocyte count, peripheral blood smear, iron profile, direct antiglobulin (Coombs) test, hemoglobin electrophoresis, osmotic fragility, enzyme assays for G6PD and pyruvate kinase, bone marrow examination, serum haptoglobin, and urinalysis.
3-7 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login